Skip to content

Anxiety research published in 2023

Page 13 of 17: studies 241 to 260 of 328, newest first. Back to the anxiety overview

Studies

The relationship between mindfulness, anxiety and depression during the COVID-19 pandemic: A meta-analysis of correlational studies

Frontiers in Psychology February 15, 2023 Fuming Xu, Wanling Zhu, Qian Chen et al.

BackgroundThe emergence of the COVID-19 pandemic has created an environment in which numerous determinants of poor mental health are intensified. Lockdown, re-lockdown, and media coverage of the spread of the virus, have the potential to contribute to increased levels of anxiety and depression. Mindfulness may act as a buffer against COVID-19-related depressive and anxiety disorders.MethodsWe...

Effects of Mindfulness and Holotropic Breathwork on the Rehabilitation of Adolescents Who Use Psychoactive Substances: A Pilot Study

Research Square February 14, 2023 Frank Sánchez-Quijano, Diana Ximena Puerta-Cortés, Julio Eduardo Mazorco-Salas preprint

Abstract This pilot study aims to compare the effects of mindfulness and holotropic breathwork treatments on adolescents in the rehabilitation process for psychoactive substance use. Participants comprised 18 female adolescents aged 15–18 admitted to the Fundación Grupo de Apoyo, affiliated with the Colombian Family Welfare Institute. The Fundación is dedicated to rehabilitation from,...

Arketamine for cognitive impairment in psychiatric disorders

European Archives of Psychiatry and Clinical Neuroscience February 14, 2023 Kenji Hashimoto 40 citations

Cognitive impairment has been observed in patients with various psychiatric disorders, including schizophrenia, major depressive disorder (MDD), and bipolar disorder (BD). Although modern therapeutic drugs can improve certain symptoms (i.e., psychosis, depression) in these patients, these drugs have not been found to improve cognitive impairment. The N-methyl-D-aspartate receptor antagonist...

Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report

Frontiers in Psychiatry February 9, 2023 Anya Ragnhildstveit, Miriam Kaiyo, Matthew Brian Snyder et al. 10 citations

Background A dissociative subtype of posttraumatic stress disorder, known as “D-PTSD”, has been included in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. In addition to meeting criteria for PTSD, patients endorse prominent dissociative symptoms, namely depersonalization and derealization, or detachment from one's self and surroundings. At present, this population is...

Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic.

Journal of adolescent and young adult oncology February 8, 2023 Carolyn S Phillips, Julianna Bockhoff, Donna L Berry et al.

Purpose: To explore adolescent and young adults' (AYAs) experiences with participation in a mindfulness-based music therapy intervention during cancer treatment before and during the COVID-19 pandemic. Methods: Sixteen young adults (20-39 years old) who received cancer treatment and participated in a mindfulness-based music therapy intervention for anxiety and stress were interviewed using a...

Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents

Biomedicines February 5, 2023 Erika Plazas, Nicoletta Faraone 40 citations

Neuropsychiatric diseases such as depression, anxiety, and post-traumatic stress represent a substantial long-term challenge for the global health systems because of their rising prevalence, uncertain neuropathology, and lack of effective pharmacological treatments. The approved existing studies constitute a piece of strong evidence whereby psychiatric drugs have shown to have unpleasant side...

DOI: 10.3390/biomedicines11020461 (opens in new tab) Anxiety Biosynthesis Clinical trials Ergot alkaloids +11

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Journal of Affective Disorders February 3, 2023 Guy M. Goodwin, Scott T Aaronson, Oscar Alvarez et al. 168 citations

Three weeks after dosing, psilocybin 25 mg and, to a lesser degree, 10 mg improved measures of patient-reported depression severity, anxiety, affect, and functioning. These results extend the primary findings from the largest randomised clinical trial of psilocybin for TRD to examine other outcomes that are of importance to patients.

DOI: 10.1016/j.jad.2023.01.108 (opens in new tab) Anxiety Psilocybin Antidepressant Patient-reported outcomes +5

The Effectiveness of Giving Cognitive Behavior Therapy (CBT) and Mindfulness Therapy on Adolescents' Social Anxiety Levels

Jurnal Aisyah : Jurnal Ilmu Kesehatan February 2, 2023 Yulia Sukmawati, Retno Lestari, V. Wardhani

Social anxiety is a serious problem occurring in early adolescence characterized by a high level of worry, negative evaluation, and avoidance behavior in various social situations. The existence of fear, worry, and unconsciousness in recognizing negative thoughts that cause avoidance in adolescents with social anxiety problems can be overcome by providing CBT and Mindfulness therapy. This study...

Neural correlates of a mindfulness-based intervention in anorexia nervosa.

BJPsych Open February 2, 2023 Tomomi Noda, Masanori Isobe, Ryo Mishima et al.

We examined the neural underpinnings of the effects of mindfulness on anxiety in anorexia nervosa using functional magnetic resonance imaging in 21 anorexia patients. We used a functional magnetic resonance imaging task designed to induce weight-related anxiety and asked participants to regulate their anxiety either using or not using an acceptance strategy. Our results showed reduced activity...

Breathwork Interventions for Adults with Clinically Diagnosed Anxiety Disorders: A Scoping Review.

Brain Sciences February 2, 2023 Blerida Banushi, Madeline Brendle, Anya Ragnhildstveit et al.

Anxiety disorders are the most common group of mental disorders, but they are often underrecognized and undertreated in primary care. Dysfunctional breathing is a hallmark of anxiety disorders; however, mainstays of treatments do not tackle breathing in patients suffering anxiety. This scoping review aims to identify the nature and extent of the available research literature on the efficacy of...

Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being

Death Studies February 2, 2023 Sam G. Moreton, Andrew F. Arena, Yolanda Foy et al. 19 citations

Research over the past several decades suggests that meaningful psychedelic experiences can engender long-term effects on subjective wellbeing. However, less research has investigated the psychological mechanisms through which these effects may emerge. In the present study, participants (N = 201) completed an online survey that retrospectively measured the acute effects of a meaningful...

DOI: 10.1080/07481187.2023.2169848 (opens in new tab) Death anxiety Affect linguistics Context archaeology Clinical psychology +3

Delving into the role of mindfulness on the relationship among creativity, anxiety, and boredom of young EFL learners

Heliyon February 1, 2023 Ling-yan Cheng

Anxiety may contribute to agitation and distress in learners that can influence learning. Along with anxiety, boredom has been the focus of many recent investigations in the context of second language (L2) learning involving young learners. Anxiety and boredom would limit learners' imagination power, and can deter creativity, one of the indispensable skills in the 21st century. Mindfulness is...

Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis.

Cannabis and Cannabinoid Research February 2023 Lia P Iglesias, Lucas Bedeschi, Daniele C Aguiar et al.

Δ9-THC (the main active compound from Cannabis sativa) and related cannabinoids have been used as drugs of abuse and as medications. They induce a complex set of emotional responses in humans and experimental animals, consisting of either anxiolysis or heightened anxiety. These discrepant effects pose a major challenge for data reproducibility and for developing new cannabinoid-based medicines....

Mindfulness-based intervention for clinical and subthreshold perinatal depression and anxiety: A systematic review and meta-analysis of randomized controlled trial.

Comprehensive Psychiatry February 1, 2023 L. Leng, Xi-Can Yin, S. Ng

OBJECTIVES About one in four mothers will experience depression and anxiety during pregnancy and within their first year following childbirth. The meta-analysis aggregated the findings of randomized controlled trials (RCTs) evaluating the immediate post-intervention and maintenance effects of MBI on perinatal depression and anxiety. METHODS A systematic search was conducted in PubMed, PsycINFO,...

Incremental Validity of Cognitive-Behavioral Therapy and Acceptance and Commitment Therapy Mechanisms for Anxiety and Panic Symptomology.

Journal of Cognitive Psychotherapy February 1, 2023 Joshua J Broman-Fulks, John J Bergquist, Christian A Hall et al.

Background: acceptance and commitment therapy (ACT) and cognitive-behavioral therapy (CBT) are empirically supported treatments for anxiety and panic disorder (PD), though they differ in their putative vulnerability and maintenance processes. The present study examined the incremental validity of several of these models' proposed core processes, including anxiety sensitivity (AS), dispositional...

Mindfulness-Based Stress Reduction a Viable Option for Treatment of Anxiety.

AJN, American Journal of Nursing February 1, 2023 Karen Rosenberg

According to this study: Mindfulness-based stress reduction is well tolerated and has comparable effectiveness to a first-line medication for people who have anxiety disorders.At least one study-related adverse event occurred in 78.6% of patients in the escitalopram group and in 15.4% of those in the mindfulness-based stress reduction group.

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

Brain Science February 1, 2023 Ahmed Hasbi, Bertha K. Madras, S. George

Background: There is a growing liberalization of cannabis-based preparations for medical and recreational use. In multiple instances, anxiety and depression are cited as either a primary or a secondary reason for the use of cannabinoids. Aim: The purpose of this review is to explore the association between depression or anxiety and the dysregulation of the endogenous endocannabinoid system...

Sitting Meditation and Mindfulness Effects on Overall Anxiety and Test Anxiety Among College Students

Mind, Brain, and Education February 1, 2023 John E. Lothes, Sara Matney, Zayne Naseer et al.

AbstractResearch shows that mindfulness interventions for test anxiety in a college student population are beneficial (Lothes, Matney, & Naseer, 2022). This study assessed the effects of online mindfulness practices over a 5‐week period on anxiety and test anxiety in college students. Participants included 20 students that were randomly assigned to either a sitting meditation or a wait list...

Chain mediating effect of insomnia, depression, and anxiety on the relationship between nightmares and cognitive deficits in adolescents.

Journal of Affective Disorders February 1, 2023 Li-Gang Zhang, Ling-Fei Cheng, Ting-Ting Wang et al.

The study explored the differences in nightmare, insomnia, depression, anxiety, and cognitive deficits among adolescents and the chain mediating effects of insomnia, depression, and anxiety on the relationship between nightmares and cognitive deficits in adolescents. An online survey was used to collect demographic data of 6014 adolescents and assess nightmare, insomnia, depression, anxiety,...

Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Biological Psychiatry February 1, 2023 Friederike Holze, Peter Gasser, Felix Müller et al. 294 citations

This study aimed to investigate the efficacy and safety of lysergic acid diethylamide (LSD)-assisted therapy in patients who experienced anxiety with or without association with a life-threatening illness. The study is an investigator-initiated 2-center trial that used a double-blind, placebo-controlled, 2-period, random-order, crossover design with 2 sessions with either oral LSD (200 μg) or...